Bio-Path Holdings, Inc.盘中异动大幅下挫9.09%

自选股智能写手03-11

北京时间2024年03月11日21时31分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫9.09%。截至发稿，该股报5.30美元/股，成交量2256股，换手率0.33%，振幅3.60%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-16.08百万美元，每股收益-33.64美元，毛利-178000.00美元，市盈率-0.16倍。机构评级方面，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2418582368?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-11 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2418582368","market":"us","top_or_hot":-1,"title":"Bio-Path Holdings, Inc.盘中异动 大幅下挫9.09%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年03月11日21时31分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫9.09%。截至发稿，该股报5.30美元/股，成交量2256股，换手率0.33%，振幅3.60%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-16.08百万美元，每股收益-33.64美元，毛利-178000.00美元，市盈率-0.16倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112131418b243b31&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bio-Path Holdings, Inc.盘中异动 大幅下挫9.09%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBio-Path Holdings, Inc.盘中异动 大幅下挫9.09%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-11 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112131418b243b31&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年03月11日21时31分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫9.09%。截至发稿，该股报5.30美元/股，成交量2256股，换手率0.33%，振幅3.60%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-16.08百万美元，每股收益-33.64美元，毛利-178000.00美元，市盈率-0.16倍。机构评级方面，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112131418b243b31&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112131418b243b31&s=b","article_id":"2418582368","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403112131418b243b31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2418582368","pubTimestamp":1710163900,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年03月11日21时31分，Bio-Path Holdings, Inc.股票出现异动，股价急速下挫9.09%。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、180 Life Sciences Corp.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为706.11%、152.81%、70.55%，振幅较大的相关个股有Equillium, Inc.、Aprea Therapeutics, Inc.、Tc Biopharm  Plc，振幅分别为11.99%、10.86%、9.43%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BPTH":"Bio-Path Holdings, Inc."},"translate_title":"Bio-Path Holdings, Inc. fell 9.09% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BPTH":1},"content_text":"北京时间2024年03月11日21时31分，Bio-Path Holdings, Inc.（BPTH.us）股票出现异动，股价急速下挫9.09%。截至发稿，该股报5.30美元/股，成交量2256股，换手率0.33%，振幅3.60%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-16.08百万美元，每股收益-33.64美元，毛利-178000.00美元，市盈率-0.16倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Bio-Path Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Biocardia Inc C/Wts 06/08/2024(To Pur Com)、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、Tc Biopharm (Holdings) Plc涨幅较大，Tc Biopharm (Holdings) Plc、180 Life Sciences Corp.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为706.11%、152.81%、70.55%，振幅较大的相关个股有Equillium, Inc.、Aprea Therapeutics, Inc.、Tc Biopharm (Holdings) Plc，振幅分别为11.99%、10.86%、9.43%。Bio-Path Holdings, Inc.公司简介：Bio-Path Holdings Inc是一家处于临床和临床前阶段，专注于肿瘤学的RNAi纳米粒子药物开发公司。它致力于利用一种新技术，该技术可实现针对疾病中过度表达的任何基因产物的靶标特异性蛋白抑制的全身递送。 该公司的主要候选药物prexigebersen正处于急性髓性白血病（AML）2期临床试验的阶段，该试验结合低剂量阿糖胞苷（LDAC）和地西他滨联合使用。此外，该公司还有其他候选药物：BP1002和BP1003。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2418582368"}

Bio-Path Holdings, Inc.盘中异动 大幅下挫9.09%

精彩评论

Bio-Path Holdings, Inc.盘中异动大幅下挫9.09%